Ledger.Open graph →
SEC Form D · Amendment · filed May 4, 2015

Amphivena Therapeutics, Inc

Offering
$14.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jeanmarie Guenot · San Francisco, CAExecPhil Gutry · Boston, MADirectorFrank Muhlenbeck · BEDFORD, MADirectorAdi Hoess · Heidelberg, 2MDirectorLuke Evnin · Boston, MADirectorRichard Y. Roberts · Hicksville, NYDirectorMatthew Ornstein · Atlanta, GADirectorJose M. De La Infiesta · BARCELONA, U3ExecEdward N. Hanson · Hicksville, NYDirectorReginald Bell · GREENVILLE, SCDirectorKyle Putnam · GREENVILLE, SCDirectorTariq C. Adawi · Kansas City, MODirectorWilliam B. Nitze · Los Angeles, CAExec · DirectorChandra Pandey · Westford, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗